Linical Company Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Linical Company Limited with three other
companies in this sector in Japan:
sales of 4.90 billion Japanese Yen [US$43.33 million]
of which 100%
was Therapeutic Medicin),
Trans Genic Inc
(2.30 billion Japanese Yen [US$20.38 million]
of which 50%
was CRO Business), and
Morishita Jintan Co., Ltd.
(10.97 billion Japanese Yen [US$97.06 million]
of which 71%
was Health Care Business).
Linical Company Limited reported sales of ¥8.36 billion (US$73.95 million)
March of 2017.
increase of 9.0%
versus 2016, when the company's sales were ¥7.67 billion.
Sales at Linical Company Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 169%).
Sales of Cso Project saw an increase
that was more than double the company's growth rate: sales were up
45.8% in 2017, from
¥553.40 million to ¥806.76 million.